Steven Madden target price cut to $40 from $45 by UBS
SHOO•UBS cut its target price for Steven Madden to $40 from $45.
Related News
Halozyme sees zero to minimal royalty revenue impact from Medicare drug pricing rule through at least 2035
HALO•
UBS raises Celsius Holdings target price to $42 from $38
CELH•
UBS raises CarGurus target price to $36 from $35
CARG•
Veeva Systems: UBS raises target price to $325 from $290
VEEV•
Perimeter Solutions, Inc.: UBS raises target price to $40 from $38
PRM•